Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer-Reference-Cited by-同舟云学术

Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer

Published:2014-01 Issue:1 Volume:83 Page:90-96
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ohgino Keiko,Soejima Kenzo,Yasuda Hiroyuki^ORCID,Hayashi Yuichiro,Hamamoto Junko^ORCID,Naoki Katsuhiko,Arai Daisuke,Ishioka Kota^ORCID,Sato Takashi,Terai Hideki^ORCID,Ikemura Shinnosuke,Yoda Satoshi^ORCID,Tani Tetsuo,Kuroda Aoi,Betsuyaku Tomoko

Funder

Ministry of Education, Culture, Sports, Science, and Technology of Japan

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Cancer statistics, 2012;Siegel;CA: A Cancer Journal for Clinicians,2012

2. TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer;Liu;Cancer Epidemiology,2013

3. Fibroblast growth factors;Ornitz;Genome Biology,2001

4. Fibroblast growth factor signaling in tumorigenesis;Grose;Cytokine & Growth Factor Reviews,2005

5. Fibroblast growth factor signalling: from development to cancer;Turner;Nature Reviews. Cancer,2010

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central composite design augmented quality-by-design-based systematic formulation of erlotinib hydrochloride-loaded chitosan-poly (lactic-co-glycolic acid) nanoparticles;Therapeutic Delivery;2024-05-09

2. The long intergenic non-coding RNA LINC01140 modulates gastric cancer phenotypes and cancer cell lines aggressiveness;Digestive and Liver Disease;2024-03

3. FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist;Cells;2024-02-07

4. The expression level of fibroblast growth factor gene in serum samples of lung cancer patients;Cellular and Molecular Biology;2023-12-20

5. FGF9, a potent mitogen, is a new ligand for integrin αvβ3, and the FGF9 mutant defective in integrin binding acts as an antagonist;2023-12-02